TickerFacts.

NeoGenomics Inc (NEO): Operating Cash Flow

Annual figures by period end, from SEC filings.

$5.23M
Year ended 2025-12-31
$22.05M
Trailing 12 months to 2026-06-30
+29.1%
5-year compound annual growth
-2.0%
10-year compound annual growth
$44.79M2010-12-31: -$2.05M2011-12-31: $69.0K2012-12-31: -$492.0K2013-12-31: $2.23M2014-12-31: $9.45M2015-12-31: $6.39M2016-12-31: $21.48M2017-12-31: $18.04M2018-12-31: $44.79M2019-12-31: $23.37M2020-12-31: $1.46M2021-12-31: -$26.72M2022-12-31: -$65.99M2023-12-31: -$1.95M2024-12-31: $7.02M2025-12-31: $5.23M$5.23M
2010-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$5.23M-25.5%2026-02-17, From 2025-01-01
2024-12-31$7.02Mn/m2026-02-17, From 2024-01-01
2023-12-31-$1.95Mn/m2026-02-17, From 2023-01-01
2022-12-31-$65.99Mn/m2025-02-18, From 2022-01-01
2021-12-31-$26.72Mn/m2024-02-20, From 2021-01-01
2020-12-31$1.46M-93.8%2023-02-24, From 2020-01-01
2019-12-31$23.37M-47.8%2022-02-25, From 2019-01-01
2018-12-31$44.79M+148.3%2021-02-25, From 2018-01-01
2017-12-31$18.04M-16.0%2020-02-28, From 2017-01-01
2016-12-31$21.48M+235.9%2019-02-26, From 2016-01-01
2015-12-31$6.39M-32.3%2018-03-13, From 2015-01-01
2014-12-31$9.45M+324.3%2017-03-14, From 2014-01-01
2013-12-31$2.23Mn/m2014-02-24, From 2013-01-01
2012-12-31-$492.0Kn/m2014-02-24, From 2012-01-01
2011-12-31$69.0Kn/m2014-02-24, From 2011-01-01
2010-12-31-$2.05Mn/a2012-03-12, From 2010-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
NeoGenomics Inc (NEO)2025-12-31$5.23M-25.5%
UL Solutions Inc. (ULS)2025-12-31$600.00M+14.5%
20/20 Biolabs, Inc. (AIDX)2025-12-31-$1.92Mn/m
Hypha Labs, Inc. (FUNI)2025-09-30-$380.0Kn/m

Compare NEO, ULS, AIDX, FUNI side by side · Screen every company in Services-Testing Laboratories ↗